Deltex Medical Group plc
DTXMF
$0.0952
$0.09223,073.33%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 0.52% | 25.18% | 1.89% | -40.32% | -3.10% |
| Total Depreciation and Amortization | -0.40% | -44.74% | -1.97% | 91.60% | 3.03% |
| Total Amortization of Deferred Charges | -0.56% | 2,705.26% | 0.00% | -84.80% | 3.31% |
| Total Other Non-Cash Items | -0.46% | -61.77% | -1.89% | 8,861.54% | 8.33% |
| Change in Net Operating Assets | 0.58% | 79.51% | 1.92% | -337.73% | 3.07% |
| Cash from Operations | 0.51% | 50.11% | 1.88% | -195.13% | -3.08% |
| Capital Expenditure | -- | -- | 0.00% | 50.00% | -5.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | 101.68% | 1.90% | 46.45% | -3.07% |
| Cash from Investing | 0.00% | 101.64% | 1.85% | 46.53% | -3.13% |
| Total Debt Issued | 0.00% | -- | -- | -100.00% | 0.00% |
| Total Debt Repaid | 0.00% | 70.41% | 0.00% | -63.33% | 0.00% |
| Issuance of Common Stock | -- | -- | 0.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00% | -- | -- |
| Cash from Financing | -0.73% | -97.25% | -1.89% | 749.79% | 3.03% |
| Foreign Exchange rate Adjustments | -1.43% | -43.55% | -2.36% | 388.64% | -2.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.50% | -164.70% | -1.90% | 266.20% | -3.08% |
